Journal
AMERICAN JOURNAL OF INFECTION CONTROL
Volume 32, Issue 6, Pages 342-344Publisher
MOSBY, INC
DOI: 10.1016/j.ajic.2004.02.008
Keywords
-
Ask authors/readers for more resources
We conducted a case-control study to determine the attributable direct costs of multidrug-resistant Acinetobacter baumannii (MDRAB) in the burn unit of a public teaching hospital. The mean total hospital cost of patients who acquired MDRAB was $98,575 higher than that of control patients who had identical burn severity of illness indices (P < .01). These data should help infection control practitioners and others determine the cost-effectiveness of specific interventions designed to control this emerging nosocomial pathogen.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available